480 related articles for article (PubMed ID: 10843188)
1. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
3. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
4. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
5. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
[TBL] [Abstract][Full Text] [Related]
6. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.
Carling T; Rastad J; Akerström G; Westin G
J Clin Endocrinol Metab; 1998 Jul; 83(7):2255-9. PubMed ID: 9661591
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.
Correa P; Rastad J; Schwarz P; Westin G; Kindmark A; Lundgren E; Akerström G; Carling T
J Clin Endocrinol Metab; 1999 May; 84(5):1690-4. PubMed ID: 10323401
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor genotypes in primary hyperparathyroidism.
Carling T; Kindmark A; Hellman P; Lundgren E; Ljunghall S; Rastad J; Akerström G; Melhus H
Nat Med; 1995 Dec; 1(12):1309-11. PubMed ID: 7489414
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.
Carling T; Ridefelt P; Hellman P; Rastad J; Akerström G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1772-5. PubMed ID: 9177380
[TBL] [Abstract][Full Text] [Related]
13. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
[TBL] [Abstract][Full Text] [Related]
14. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
15. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
[TBL] [Abstract][Full Text] [Related]
18. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
[TBL] [Abstract][Full Text] [Related]
19. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
Rodriguez ME; Almaden Y; Cañadillas S; Canalejo A; Siendones E; Lopez I; Aguilera-Tejero E; Martin D; Rodriguez M
Am J Physiol Renal Physiol; 2007 May; 292(5):F1390-5. PubMed ID: 17200160
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
